AngioDynamics
ANGO
138 hedge funds and large institutions have $251M invested in AngioDynamics in 2024 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 59 increasing their positions, 36 reducing their positions, and 21 closing their positions.
139% more call options, than puts
Call options by funds: $74K | Put options by funds: $31K
64% more repeat investments, than reductions
Existing positions increased: 59 | Existing positions reduced: 36
28% more capital invested
Capital invested by funds: $197M → $251M (+$54.3M)
5% less first-time investments, than exits
New positions opened: 20 | Existing positions closed: 21
1% less funds holding
Funds holding: 140 → 138 (-2)
1.74% less ownership
Funds ownership: 81.21% → 79.48% (-1.7%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SBH
Segall Bryant & Hamill
Chicago,
Illinois
|
+$3.87M |
| 2 |
Millennium Management
New York
|
+$3.19M |
| 3 |
SFM
Systematic Financial Management
Teaneck,
New Jersey
|
+$2.17M |
| 4 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.74M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ECM
ExodusPoint Capital Management
New York
|
-$6.89M |
| 2 |
Morgan Stanley
New York
|
-$3.42M |
| 3 |
WSL
Western Standard LLC
Los Angeles,
California
|
-$3.18M |
| 4 |
PCMI
Paradigm Capital Management Inc
Albany,
New York
|
-$2.89M |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.86M |
ANGO Hedge Fund Activity: Q3 2024 in Review
138 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in AngioDynamics (ANGO) for Q3 2024, worth a combined $251M — up 28% from $197M a quarter earlier.
Sellers outnumbered buyers: 21 funds closed out of ANGO and 20 opened new positions — a net loss of 1 holder — while 36 trimmed existing stakes and 59 added.
The largest buyer was Segall Bryant & Hamill, adding an estimated $3.87M. The largest seller was ExodusPoint Capital Management, cutting an estimated $6.89M.
- 138 institutional investors held AngioDynamics (ANGO) as of Q3 2024, down from 140 in Q2 2024.
- Funds reported $251M of AngioDynamics stock for Q3 2024, up 28% quarter-over-quarter.
- 20 funds opened new AngioDynamics positions in Q3 2024 and 21 closed out, a net change of -1 holder.
- The largest AngioDynamics buyer in Q3 2024 was Segall Bryant & Hamill, an estimated $3.87M added.
- The largest AngioDynamics seller in Q3 2024 was ExodusPoint Capital Management, an estimated $6.89M sold.
Based on aggregated 13F filings for Q3 2024.